(Q36612496)

15 August 2017

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis (English)

1 reference

15 August 2017

1 reference

Y C Yang

1

1 reference

15 August 2017

M L Lu

2

1 reference

15 August 2017

J Y Rao

3

1 reference

15 August 2017

H Wallerand

4

1 reference

15 August 2017

L Cai

5

1 reference

15 August 2017

W Cao

6

1 reference

15 August 2017

A Pantuck

7

1 reference

15 August 2017

G Dalbagni

8

1 reference

15 August 2017

V Reuter

9

1 reference

15 August 2017

R A Figlin

10

1 reference

15 August 2017

A Belldegrun

11

1 reference

15 August 2017

C Cordon-Cardo

12

1 reference

15 August 2017

Z F Zhang

13

1 reference

15 August 2017

language of work or name

English

0 references

publication date

7 November 2006

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

95

1 reference

15 August 2017

1455-1458

1 reference

15 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603456

15 August 2017

0 references

cites work

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Fibroblast growth factors, their receptors and signaling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

No evidence of somatic FGFR3 mutation in various types of carcinoma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360734

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603456

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17088904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17088904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17088904

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6603456

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference